Copertina

Treatment of thrombotic cardiovascular diseases in people with haemophilia: A Japanese consensus study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Azusa Nagao, Yushi Chikasawa, Yukio Hiroi, Masahiro Ieko
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Haemophilia
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The First Three Japanese Haemophilia A Patients in Whom Factor VIII Inhibitors Were Observed During Prophylactic Treatment With Efanesoctocog Alfa
di: Tazuko Tokugawa, et al.
Pubblicazione: (2025)

Preference of treatment characteristics among people with haemophilia or their caregivers, and physicians in the Japanese healthcare environment
di: Teruhisa Fujii, et al.
Pubblicazione: (2024)

Democratisation of physiotherapy for people with haemophilia
di: Carlos Cruz‐Montecinos, et al.
Pubblicazione: (2024)

Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel
di: Mike Laffan, et al.
Pubblicazione: (2024)

Sexual functioning in men with haemophilia: Data from the haemophilia in the Netherlands‐6 study
di: Tessa C. M. van Gastel, et al.
Pubblicazione: (2024)

Assessing the factors affecting the accessibility of primary dental care for people with haemophilia
di: Kitti Sipos, et al.
Pubblicazione: (2024)

Comparison of the kinematic analysis of indoor and outdoor gait in people with haemophilia and total knee replacement
di: Carlos Cruz‐Montecinos, et al.
Pubblicazione: (2024)

Alleviated bleeding phenotypes in a child with severe haemophilia A and thalassemia disease
di: Pongpak Pongphitcha, et al.
Pubblicazione: (2024)

The haemophilia joint health score for the assessment of joint health in patients with haemophilia
di: Cihan Ay, et al.
Pubblicazione: (2024)

Race and ethnicity and the success of immune tolerance induction among people with severe haemophilia A in the United States
di: Stacey A. Fedewa, et al.
Pubblicazione: (2024)

Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry
di: Nadine G. Andersson, et al.
Pubblicazione: (2024)

Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes
di: Vuokko Nummi, et al.
Pubblicazione: (2024)

Challenges in ageing persons with haemophilia
di: Michael Makris, et al.
Pubblicazione: (2024)

Self‐conducted sonographic monitoring of the knee in patients with haemophilia—A feasibility study
di: Anna Christina Strauss, et al.
Pubblicazione: (2024)

How much prophylaxis is enough in haemophilia?
di: Manuel Carcao, et al.
Pubblicazione: (2024)

Development of the coreHEM mental health patient‐reported outcome measure – A novel mental health outlook measure for people with haemophilia
di: Elizabeth Clearfield, et al.
Pubblicazione: (2024)

Quality of life of siblings of adolescents with severe haemophilia (FRATHEMO): An ancillary study to the TRANSHEMO project
di: Ngoc Anh Thu Nguyen, et al.
Pubblicazione: (2024)

Unearthing the genotype‐inhibitor phenotype association in severe haemophilia A: A north Indian cohort study
di: Debadrita Ray, et al.
Pubblicazione: (2024)

Humanistic burden of haemophilia A without inhibitors: A cross‐sectional analysis of the HemoLIFE study
di: María Teresa Álvarez‐Román, et al.
Pubblicazione: (2024)

Women and girls’ participation in haemophilia clinical trials
di: Stacey A. Fedewa, et al.
Pubblicazione: (2024)

The impact of emicizumab on the clinical validation of new therapies for haemophilia A
di: Cedric Hermans, et al.
Pubblicazione: (2024)

Development of Awareness Materials to Promote Early Diagnosis of Undiagnosed von Willebrand Disease: Integration of Multidisciplinary Perspectives Based on a Literature Review
di: Azusa Nagao, et al.
Pubblicazione: (2025)

Defining success in haemophilia care – Are we doing it right?
di: Alok Srivastava
Pubblicazione: (2024)

Acute neuromuscular and perceptual responses to blood flow restriction exercise in adults with severe haemophilia: A pilot study
di: Daniel C. Ogrezeanu, et al.
Pubblicazione: (2024)

Patient and caregiver preferences for haemophilia treatments: A discrete‐choice experiment
di: Viridiana Cano Garcia, et al.
Pubblicazione: (2024)

A clinical practice guideline for primary care physiotherapy in patients with haemophilia
di: Johan Blokzijl, et al.
Pubblicazione: (2024)

Emicizumab plasma levels after accelerated saturation in acquired haemophilia A
di: Tristan Kloeter, et al.
Pubblicazione: (2024)

Functional clinical motor performance tests to assess potential fall risks in patients with haemophilia: A case‐control study
di: Fabian Tomschi, et al.
Pubblicazione: (2024)

Benefits of physical activity self‐monitoring in patients with haemophilia: a prospective study with one‐year follow‐up
di: Sofía Pérez‐Alenda, et al.
Pubblicazione: (2024)

Bone mineral density in haemophilia patients: A systematic review and meta‐analysis
di: Meiling Zhang, et al.
Pubblicazione: (2024)

Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective
di: Wolfgang Miesbach, et al.
Pubblicazione: (2024)

Differences and similarities in patient‐reported outcomes among men and women with haemophilia
di: Christine L. Kempton, et al.
Pubblicazione: (2024)

EAHAD haemophilia gene therapy clinical outcome database (EAHAD‐GTD)
di: Wolfgang Miesbach, et al.
Pubblicazione: (2024)

Dentistry for patients with haemophilia: Trialling a safe and economical change in management
di: Pritam Daniel Sundaresan, et al.
Pubblicazione: (2024)

The frequency of sarcopenia in haemophilia patients: Effects on musculoskeletal health and functional performance
di: Bora Uzuner, et al.
Pubblicazione: (2024)

Is pharmacological thromboprophylaxis necessary in persons with haemophilia undergoing major orthopaedic surgery?
di: Silvia Linari, et al.
Pubblicazione: (2024)

EAHAD statement on the ISTH clinical practice guideline for treatment of congenital haemophilia A and B
di: Pratima Chowdary, et al.
Pubblicazione: (2024)

Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A
di: Jens Müller, et al.
Pubblicazione: (2024)

Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A
di: Pål André Holme, et al.
Pubblicazione: (2024)

Primary prophylaxis implementation and long‐term joint outcomes in Swedish haemophilia A patients
di: Alexandros Arvanitakis, et al.
Pubblicazione: (2024)